Addition of all-<i>trans</i>-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia

Abstract

The use of conventional therapy plus ATRA for gastric dysplasia was associated with improved efficacy compared with conventional therapy alone. It was also accompanied by increased Rb expression and decreased HER2 expression in gastric mucosa. The addition of ATRA to conventional therapy for gastritis may improve the prognosis of gastric dysplasia.